找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Universalising Healthcare in India; From Care to Coverag Imrana Qadeer,K. B. Saxena,P. M. Arathi Book 2021 The Editor(s) (if applicable) an

[復(fù)制鏈接]
樓主: morphology
11#
發(fā)表于 2025-3-23 12:18:16 | 只看該作者
12#
發(fā)表于 2025-3-23 16:09:45 | 只看該作者
13#
發(fā)表于 2025-3-23 19:46:27 | 只看該作者
Interrogating the Proposed Universal Healthcare in India Through a ‘Quality’ LensRising health inequalities, catastrophic healthcare costs pushing people below the poverty line, along with glaring gaps between economic growth rates and health status of people have raised many questions about the post-liberalisation health sector reforms in India.
14#
發(fā)表于 2025-3-24 02:12:25 | 只看該作者
15#
發(fā)表于 2025-3-24 03:23:29 | 只看該作者
Role of Public Private Partnerships in Ensuring Universal Healthcare for IndiaIn the early 1990s Health Sector Reforms (HSR) undertaken as part of structural adjustment programmes proposed a range of changes in governance, provisioning, financing and resource generation.
16#
發(fā)表于 2025-3-24 06:31:07 | 只看該作者
17#
發(fā)表于 2025-3-24 12:00:51 | 只看該作者
Universal Healthcare and Universalising Health Insurance: Examining the Binary Through the RSBY/MSBYThe Rashtriya Swasthya Bima Yojana (RSBY) is a state-funded health insurance scheme in India, targeted at families living Below Poverty Line (BPL).
18#
發(fā)表于 2025-3-24 15:14:42 | 只看該作者
Aarogyasri Scheme in Andhra Pradesh, India: Some Critical ReflectionsUniversal Health Coverage (UHC) is currently being debated all over the world and the ruling Bharatiya Janata Party (BJP) government in India has now brought in the idea of health assurance.
19#
發(fā)表于 2025-3-24 20:36:06 | 只看該作者
20#
發(fā)表于 2025-3-25 01:04:48 | 只看該作者
Drugs and Vaccines in Healthcare: Problems and PossibilitiesThe problems with regard to the use of allopathic drugs in India range from quality and regulation to irrational use because of the nexus between pharmaceutical companies and the largely commercial healthcare establishments. Fake or sub-standard allopathic drugs may represent as much as 25% of our drugs.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 17:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
石渠县| 镇沅| 盐山县| 广丰县| 东莞市| 淳化县| 东山县| 钟祥市| 虞城县| 柳河县| 绥中县| 高台县| 瑞昌市| 环江| 上杭县| 和静县| 镇江市| 武功县| 湄潭县| 辽宁省| 罗平县| 望奎县| 蓝山县| 离岛区| 佛山市| 石屏县| 建平县| 和林格尔县| 册亨县| 开鲁县| 龙游县| 嵊州市| 嘉祥县| 华亭县| 蒙自县| 白朗县| 页游| 清水河县| 井陉县| 布尔津县| 灌阳县|